LCM
LSBPW

Landscape Capital Management’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Landscape Capital Management’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$470 – 649
2023
Q2 		$470 Hold
10,000
– – ﹤0.01% 552
2023
Q1 		$1.56K Buy
+10,000
New +$1.51K ﹤0.01% 602

Other funds holding LSBPW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Landscape Capital Management's LSBPW Position: Q3 2023 in Review

Landscape Capital Management sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2023, closing a stake of 10,000 shares — an estimated $470 sold.

Landscape Capital Management first reported a position in LSBPW in Q1 2023 and held it in 2 quarters. The position peaked at $1.56K in Q1 2023. 30 funds tracked by Wall St. Rank hold LSBPW as of Q3 2023.

  • Landscape Capital Management reported no remaining LakeShore Biopharma Warrants position as of Q3 2023 after selling out during the quarter.
  • Landscape Capital Management sold 10,000 LakeShore Biopharma Warrants shares in Q3 2023, an estimated $470.
  • Landscape Capital Management first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 2 quarters.
  • Landscape Capital Management's LakeShore Biopharma Warrants position peaked at $1.56K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2023.

Based on Landscape Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.